At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 94 enrolled
Drug / intervention
Tranexamic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin / Hematocrit in Isolated Operative Posterior Wall Acetabular Fractures: a Prospective, Randomized, Double-blinded, Multicenter Study
In Brief
A Early Phase 1 clinical trial evaluating Tranexamic Acid and Normal saline for Fracture of Posterior Wall of Acetabulum. Completed, enrolled 94 participants across 1 site.
Detailed Summary
This multi-center, prospective study will evaluate the use of topical tranexamic acid (TXA - Cyklokapron; Pfizer, New York, NY) on pre-operative and post-operative hemoglobin (Hb)/hematocrit (Hct) in patients undergoing operative repair of isolated posterior wall (PW) acetabular fractures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFracture of Posterior Wall of Acetabulum
CountriesUnited States
CollaboratorsFoundation for Orthopedic Trauma
Timeline
Early Ph 1CompletedFinished
201820192020202120222023202420252026
Enrollment StartAug 2017
First PostedMay 2022
Primary CompletionAug 2024
Study CompletionDec 2024
TodayJul 2026
First PostedMay 2, 2022
Enrollment StartAug 25, 2017
Primary CompletionAug 30, 2024
Study CompletionDec 2, 2024
TodayJul 2, 2026
Enrollment to primary: 7.0 yearsPosted 4.2 years ago
Interventions
Tranexamic Aciddrug
Topical application
Normal salinedrug
Topical application